COMMUNIQUÉS West-GlobeNewswire

NewGen Establishes New Joint Venture Dedicated to Real Estate Development in UAE
08/10/2025
An agreement signed between NewGen and BNW will establish a joint venture to develop NewGen’s recently acquired plot of land in Ras Al Khaimah’s Beach District, UAE Feasibility studies indicate potential net returns for [...]
VIVUS Announces QSYMIA® Price Reduction at Costco Pharmacies Nationwide
08/10/2025
— Lowered price at retail pharmacy to expand access to overweight or obesity treatment to more patients CAMPBELL, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the [...]
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
08/10/2025
The Company is well on track with Phase 1 enrollment now that both patients in Cohort 3 have successfully initiated treatment with no evidence of dose-limiting toxicities or tolerability concerns to date The first [...]
Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
08/10/2025
Study Demonstrated a Sensitivity of 100% and Specificity of 95% Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, [...]
Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy
08/10/2025
Investment creates the world’s first Strategic Compute Reserve Strategy complements Predictive Oncology’s AI/ML-driven drug discovery and development activities PITTSBURGH, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Predictive [...]
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow
08/10/2025
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and sustained profitability with its eleventh consecutive half of positive Adjusted EBITDA [...]
Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity
08/10/2025
Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date MENLO PARK, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB [...]
Intuitive expands AI and advanced imaging integration in Ion Endoluminal System
08/10/2025
FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures SUNNYVALE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology [...]
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow
08/10/2025
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and sustained profitability with its eleventh consecutive half of positive Adjusted EBITDA [...]
Triumph Steps Scales Proven Transformative Coaching Certification for Mental Health Professionals
08/10/2025
New Certification Empowers Therapists and Coaches to Reclaim Purpose and Expand Impact Miami, Florida, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Triumph Steps , a leader in emotional literacy education, today announced the [...]
Baylor Genetics to Showcase Clinical and Diagnostic Utility of Genome Sequencing and Multi-omics Across Rare Disease at the American Society of Human Genetics 2025 Annual Meeting
08/10/2025
Company to share eight poster presentations highlighting advanced diagnostic tools to gain critical insights and shorten the diagnostic odyssey HOUSTON, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics , a clinical [...]
Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions announce an ‘Integrated CMC Partnership’ to accelerate drug development for innovators
08/10/2025
MANCHESTER, United Kingdom and HYDERABAD, India, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), Agility Life Sciences, and Centrix Pharma Solutions today announced the launch of an [...]
Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple Sclerosis
08/10/2025
- Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now in Phase 3 development for progressive forms of Multiple Sclerosis (MS [...]
Confo Therapeutics Awarded VLAIO Grant for Development of Ultra-Long-Acting Antibody-Based GPCR Therapeutics in Endocrine and Metabolic Conditions
08/10/2025
Ghent, Belgium – October 8, 2025 – Confo Therapeutics , a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has secured a EUR 1 million grant from Flanders [...]
Immuron Submits IMM-529 IND to FDA
08/10/2025
Key Points Immuron submits Investigational new drug (IND) application to FDA for clinical development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI) Previous clinical [...]
FDA Clears Celon Pharma’s Schizophrenia Drug for Phase 3 Trial
08/10/2025
FDA clears path for Phase 3 testing following positive Type B meeting Regulatory alignment confirms preclinical data sufficient for pivotal initiation Phase 3 to include two 28-day trials and a 12-month safety extension [...]
ITM Presents Dosimetry Data from Phase 3 COMPETE Trial Supporting Favorable Efficacy and Safety Profile with n.c.a. 177Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors at EANM 2025 Annual Congress
08/10/2025
Study showed targeted tumor uptake with low healthy organ exposure in broad cohort of 207 patients Supports therapeutic potential of ITM’s proprietary targeted radiotherapeutic agent Abstract receives prestigious EANM [...]
Newcastle Set To Benefit From New Technology to Diagnose Disease
08/10/2025
Newcastle University has entered into a lease agreement with Curium for a new site dedicated to the manufacture of cutting-edge diagnostic technologies for diseases such as cancer. The facility will be operated by [...]
Oxford Set To Benefit From New Technology to Diagnose Disease
08/10/2025
Curium will shortly open a new facility to manufacture cutting-edge diagnosis technology for diseases like cancer at the Churchill Hospital site, part of Oxford University Hospitals NHS Foundation Trust. Curium is a [...]

Pages